Signaling from toxic metals to NF-κB and beyond: Not just a matter of reactive oxygen species

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 5, 2002, Pages 807-811

  Chen, Fei ^a   Shi, Xianglin ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Kinase; Metals; NF B; Oxidative stress; Signal transduction

Indexed keywords

APOPTOSIS INDUCING FACTOR; APOPTOSIS INHIBITOR; ARSENIC; CELL ADHESION MOLECULE; CHEMOKINE; CHROMIUM; CYTOKINE; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METAL DERIVATIVE; REACTIVE OXYGEN METABOLITE; VANADIC ACID;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 0036805108     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110s5807     Document Type: Article

References (74)

1. Nelson N. Metal ion transporters and homeotasis. EMBO J 18:4361-4371 (1999).
2. Andre ws GK. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 59:95-104 (2000).
3. Beyersmann D. Interactions in metal carcinogenicity. Toxicol Lett 72:333-338 (1994).
4. Haus BM, Razavi H, Kuscher WG. Occupational and environmental causes of bronchogenic carcinoma. Curr Opin Pulm Med 7:220-225 (2001).
5. Ryan PB, Huet N, MacIntosh DL. Longitudinal investigation of exposure to arsenic, cadmium, and lead in drinking water. Environ Health Perspect 108:731-735 (2000).
6. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 100:57-70 (2000).
7. Chen F, Castranova V, Shi X. New insights into the role of nuclear factor-κB in cell growth regulation. Am J Pathol 158:387-397 (2001).
8. Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14:649-683 (1996).
9. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immnol 18:621-663(2000).
10. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260(1998).
11. Israel A. The IKK complex: an integrator of the signals that activate NF-κB? Trends Cell Biol 10:129-133 (2000).
12. Tojima Y, Fujimoto A, Delhase M, Chen Y, Hatakeyama S, Nakayama K, Kaneko Y, Nimura Y, Motoyama N, Ikeda K, et al. NAK is an IκB kinase-activating kinase. Nature 404:778-782 (2000).
13. Lee FS, Peters RT, Dang LC, Maniatis T. MEKK1 activates both IκB kinase α and IκB kinase β. Proc Natl Acad Sci USA 95:9319-9324 (1998).
14. Romashkova JA, Makarov SS. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86-90 (1999).
15. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K. The kinase TAK1 can activate the NIK-I κB as well as the MAP kinase cascade in the IL-1 sigalling pathway. Nature 398:252-256 (1999).
16. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is ubiquitin-dependent kinase of MKK and IKK. Nature 412:346-351 (2001).
17. Hehner SP, Hofman TG, Ushmorow A, Dienz O, Wing-Lan Leung I, Lassam N, Scheidereit C, Droge W, Schmitz ML. Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IκB kinase complex. Mol Cell Biol 20:2556-2568 (2000).
18. Lallena MJ, Diaz-Meco MT, Bren G, Paya CV, Moscat J. Activation of IκB kinase β by protein kinase C isoforms. Mol Cell Biol 19:2180-2188 (1999).
19. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H, Okumura K. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinas/ERK kinase kinase-1. Proc Natl Acad Sci USA 95:3537-3542 (1998).
20. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293:1495-1499 (2001).
21. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M. IKKα controls formation of the epidermis independently of NF-κB. Nature 410:710-714 (2001).
22. Peters RT, Liao SM, Maniatis T. IKKε is part of a novel PMA-inducible IκB kinase complex. Mol Cell 5:513-522 (2000).
23. Shimada T, Kawai T, Takeda K, Matsmoto M, Inoue J, Tatsumi Y, Kanamaru A, Akira S. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases. Int Immunol 11:1357-1362 (1999).
24. Pomerantz JL, Baltimore D. NK-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18:6694-6704 (1999).
25. Kishore N, Huynh QK, Mathialagan S, Hall T, Rouw S, Creely D, Lange G, Caroll J, Reitz B, Donnelly A. IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, IKK-2. J Biol Chem 277:13840-13847 (2002).
26. Nomura F, Kawai T, Nakanishi K, Akira S. NF-κB activation through IKK-i-depenent I-TRAF/TANK phosphorylation. Genes Cells 5:191-202 (2000).
27. Chariot A, Leonardi A, Muller J, Bonif M, Brown k, Siebenlist U. Association of the adaptor TANK with the IκB-kinase (IKK) regulator NEMO connects IKK complexes with IKKε and TBK1 kinases. J Biol Chem 19:19. (2002).
28. Chen F, Ding M, Castranova V, Shi X. Carcinogenic metals and NK-κB activation. Mol Cell Biochem 222:159-171 (2001).
29. Kaltreider RC, Pesce CA, Ihnat MA, Lariviere JP, Hamilton JW. Differential effects of arsenic(III) and chromium(VI) on nuclear transcription factor binding. Mol Carcinog 25:219-229 (1999).
30. Roussel RR, Barchowsky A. Arsenic inhibits NF-kappaB-mediated gene transcription by locking IκB kinase activity and IκBα phosphorylation and degradation. Arch Biochem Biophys 377:204-212 (2000).
31. Shumilla JA, Broderick RJ, Wang Y, Barchowsky A. Chromium(VI) inhibits the transcriptional activity of nuclear factor-κB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein. J Biol Chem 274:36207-36132 (1999).
32. Barchowsky A, Dudek EJ, Treadwell MD, Wetterhahn KE. Arsenic inuces oxidant stress and NK-κB activation in cultured aortic endothelial cells. Free Radic Biol Med 21:783-790 (1996).
33. Hamilton JW, Kaltreider RC, Bajenova OV, Ihnat MA McCaffrey J, Turpie BW, Rowell EE, Oh J, Nemeth MJ, Pesce CA, Lariviere JP. Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environ Health Perspect 106 (suppl 4):1005-1015 (1998).
34. Jaspers I, Samet JM, Reed W. Arsenite exposure fo cultured airway epithelial cells activates κB-dependent interleukin-8 gene expression in the absence of nuclear factof-κB nuclear translocation. J Biol Chem 274:31025-31033 (1999).
35. Kapahi P, Takahashi T, Natoli G, Adams SR, Chen Y, Tsien RY, Karin M. Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase. J Biol Chem 275:36062-36066 (2000).
36. Shumilla JA, Wetterhahn KE, Barchowsky A. Inhibition of NF-κB binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. Arch Biochem Biophys 349:356-362 (1998).
37. Chen F. Unpublished data.
38. Che F, Lu Y, Zhang Z, Vallyathan V, Ding M, Castranova V, Shi X. Opposite effect of NF-κB and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite. J Biol Chem 276:11414-11419 (2001).
39. Carter JD, Ghio AJ, Samet JM, Devlin RB. Cytokine production by human airway epithelial cells after exposure to an air pollution particle is metal-dependent Toxicol Appl Pharmacol 146:180-188 (1997).
40. Zhang L, Rie AB, Adler K, Sannes P, Martin L, Gladwell W, Koo JS, Gray TE, Bonner JC. Vanadium stimulates human bronchial epithelial cells to produce heparin-binding epidermal growth factor-like growth factor: a mitogen for lung fibroblasts. Am J Respir Cell Mol Biol 24:123-131 (2001).
41. 4) coordination mode. J Biol Inorg Chem 6:128-132 (2001).
42. Chen F, Demers LM, Vallyathan V, Ding M, Lu Y, Castranova V, Shi X. Vanadate induction of NF-κB involves IκB kinase β and SAPK/ERK kinase 1 in macrophages. J Biol Chem 274:20307-20312 (1999).
43. Schieven GL, Kirihara JM, Myers DE, Ledbetter JA, Uckun FM. Reactive oygen intermediates activate NF-κB in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes. Blood 82:1212-1220 (1993).
44. Imbert V, Peyron JF, Farahi Far D, Mari B, Auberger P, Rossi B. Induction of tyrosine phosphorylation and T-cell activaton by vanadate peroxide, an inhibitor of protein tyrosine phosphatases. Biochem J 297:163-173 (1994).
45. Barbeau B, Bernier R, Dumais N, Briand G, Olivier M, Faure R, Posner BI, Tremblay M. Activation of HIV-1 long terminal repeat transcription and virus replicationn via NF-κB-depedent and-independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds. J Biol Chem 272:12968-12977 (1997).
46. Mukhopadhyay A, Manna SK, Aggarwal BB. Pervanadate-induced nuclear factor-κB activation requires tyrosine phophorylation and degradation of IκBα. Comparison with tumor necrosis factor-α. J Biol Chem 275:8549-8555 (2000).
47. Krejsa CM, Nadler SG, Esselstyn JM, Kavanagh TJ, Ledbetter JA, Schieven GL. Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. Redox independent activation of NF-κB. J Biol Chem 272:11541-11549 (1997).
48. Cortizo AM, Bruzzone L, Molinuevo S, Etcheverry SB. A possible role of oxidative stress in the vanadium-induced cytotoxicity in the MC3T3E1 osteoblast and UMR106 osteosarcoma cell lines. Toxicology 147:89-99 (2000).
49. Barceloux DG. Chromium. J Toxicol Clin Toxicol 37:173-194(1999).
50. Alexander BH, Checkoway H, Wechsler L, Heyer NJ, Muhm JM, O'Keeffe TP. Lun cancer in chromate-exposed aerospace workers. J Occup Environ Med 38:1253-1258 (1996).
51. Ye J, Zhang X, Young HA, Mao Y, Shi X. Chromium(VI)-induced nuclear factor-κB activation in intact cells via free radical reactions. Carcinogenesis 16:2401-2405 (1995).
52. Chen F, Ding M, Lu Y, Leonard SS, Vallyathan V, Castranova V, Shi X. Participation of MAP kinase p38 and IκB kinase in chromium (VI)-induced NF-κB and AP-1 activation. J Environ Pathol Toxicol Oncol 19:231-238 (2000).
53. Chen F, Bower J, Leonard SS, Ding M, Lu Y, Rojanasakul Y, Kung HF, Vallyathan V, Castranova V, Shi X. Protective roles of NF-κB for chromium(VI)-induced cytotoxicity is revealed by expression of IκB kinase-β mutant. J Biol Chem 277;3342-3349 (2002).
54. Chaturvedi MM, Mukhopadhyay A, Aggarwal BB. Assay for redox-sensitive transcription factor. Methods Enzymol 319:585-602(2000).
55. Christman JW, Blackwell TS, Juurlink BH. Redox regulation of nuclear factor κB: therapeutic potential for attenuating inflammatory responses. Brain Pathol 10:153-162 (2000).
56. Salnikow K, Su W, Blagosklonny MV, Costa M. Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res 60:3375-3378 (2000).
57. Flohe L, Brigelius-Flohe R, Saliou C, Traber MG, Packer L. Redox regulation of NF-κB activation. Free Radic Biol Med 22:1115-1126(1997).
58. Israel N, Gougerot-Pocidalo MA, Aillet F, Virelizier JL. Redox status of cells influences constitutive or induced NF-κB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J Immunol 149:3386-3393 (1992).
59. Anderson MT, Staal FJ, Gitler C, Herzenberg LA. Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc Natl Acad Sci USA 91:11527-11531 (1994).
60. Brennan P, O'Neill LA. Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta 1260:167-175 (1995).
61. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 22:269-285(1997).
62. Suzuki YJ, Packer L. Inhibition of NF-kappa B DNA binding activity by α-tocopheryl succinate. Biochem Mol Biol Int 31:693-700 (1993).
63. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT. Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acid Res 20:3821-3830 (1992).
64. Toledano MB, Leonard WJ. Modulation transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA 88:4328-4332 (1991).
65. Hayashi T, Ueno Y, Okamoto T. Oxidoreductive regulation of nuclear factor κB. Involvement of a cellular reducing catalyst thioredoxin. J Biol Chem 268:11380-11388 (1993).
66. Marshall HE, Merchant K, Stamler JS. Nitrosation and oxidation in the regulation of gene expression. FASEB J 14:1889-1900 (2000).
67. Chen F, Kuhn DC, Sun SC, Gaydos LJ, Demers LM. Dependence and reversal of nitric oxide production on NF-κB in silica and lipopolysaccharide-induced macrophages. Biochem Biophys Res Commun 214:839-846 (1995).
68. Li N, Karin M. Is NF-κB the sensor of oxidative stress? FASEB J 13:1137-1143 (1999).
69. Bowie A, O'Neill LA. Oxidative stress and nuclear factor-κB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59:13-23 (2000).
70. Li N, Karin M. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms. Proc Natl Acad Sci USA 95:13012-13017 (1998).
71. Korn SH, Wouters EF, Vos N, Janssen-Heininger YM. Cytokine-induced activation of nuclear factor-κB is inhibited by hydrogen peroxide through oxidative inactivation of IκB kinase. J Biol Chem 276:35693-35700 (2001).
72. Jaspers I, Zhang W, Fraser A, Samet JM, Reed W. Hydrogen peroxide has opposing effects on IKK activity and IκBα breakdown in airway epithelial cells. Am J Respir Cell Mol Biol 24:769-777 (2001).
73. 2-induced cell death via coordinated regulation of stress kinases. Cancer Res 60:4053-4057 (2000).
74. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 403:103-108 (2000).